Eisner Mark

Director, EVP and Chief Medical Officer, EVP and Chief Medical Officer, EVP, Chief Medical Officer, Chief Medical Officer, Incoming Chief Medical Officer · SEC CIK 1834161
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$720.6K
12 trades
Net flow
−$720.6K
Net selling
Total filings
30
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
VIR
Sell Eisner Mark · EVP and Chief Medical Officer · Open-market sale · filed Feb 26, 2026 ΔOwn −1.2%

Eisner Mark sold $18.5K of VIR, trimming their stake 1%.

−$18.5K
1,889 sh @ $10
VIR
Sell Eisner Mark · EVP and Chief Medical Officer · Open-market sale · filed Feb 26, 2026 ΔOwn −1.0%

Eisner Mark sold $15.4K of VIR, trimming their stake 1%.

−$15.4K
1,616 sh @ $10
VIR
Sell Eisner Mark · EVP and Chief Medical Officer · Open-market sale · filed Feb 24, 2026 ΔOwn −1.3%

Eisner Mark sold $15.6K of VIR, trimming their stake 1%.

−$15.6K
2,089 sh @ $7
VIR
Sell Eisner Mark · EVP and Chief Medical Officer · Open-market sale · filed Jul 17, 2025 ΔOwn −3.3%

Eisner Mark sold $19.6K of VIR, trimming their stake 3%.

−$19.6K
3,586 sh @ $5
Advertisement
VIR
Sell Eisner Mark · EVP and Chief Medical Officer · Open-market sale · filed Jul 17, 2025 ΔOwn −5.9%

Eisner Mark sold $37.2K of VIR, trimming their stake 6%.

−$37.2K
6,796 sh @ $5
FGEN
Tax withholding Eisner Mark · EVP, Chief Medical Officer · Tax withholding · filed Sep 8, 2023 ΔOwn −1.1%
−$1.8K
1,860 sh @ $1
FGEN
Tax withholding Eisner Mark · EVP, Chief Medical Officer · Tax withholding · filed Sep 6, 2023 ΔOwn −0.7%
−$1.2K
1,085 sh @ $1
FGEN
Sell Eisner Mark · EVP, Chief Medical Officer · Open-market sale · filed Jun 9, 2023 ΔOwn −1.2%

Eisner Mark sold $34.8K of FGEN, trimming their stake 1%.

−$34.8K
2,042 sh @ $17
FGEN
Sell Eisner Mark · EVP, Chief Medical Officer · Open-market sale · filed Jun 5, 2023 ΔOwn −0.7%

Eisner Mark sold $20.5K of FGEN, trimming their stake 1%.

−$20.5K
1,090 sh @ $19
FGEN
Sell Eisner Mark · Chief Medical Officer · Open-market sale · filed Apr 6, 2023 ΔOwn −5.2%

Eisner Mark sold $172.5K of FGEN, trimming their stake 5%.

−$172.5K
9,182 sh @ $19
FGEN
Sell Eisner Mark · Chief Medical Officer · Open-market sale · filed Mar 10, 2023 ΔOwn −2.1%

Eisner Mark sold $78.5K of FGEN, trimming their stake 2%.

−$78.5K
3,885 sh @ $20
FGEN
Sell Eisner Mark · Chief Medical Officer · Open-market sale · filed Mar 10, 2023 ΔOwn −3.4%

Eisner Mark sold $126.3K of FGEN, trimming their stake 3%.

−$126.3K
6,255 sh @ $20
FGEN
Sell Eisner Mark · Chief Medical Officer · Open-market sale · filed Mar 10, 2023 ΔOwn −4.3%

Eisner Mark sold $155.8K of FGEN, trimming their stake 4%.

−$155.8K
7,363 sh @ $21
FGEN
Grant/award Eisner Mark · Chief Medical Officer · Grant/award · filed Mar 10, 2023 ΔOwn +7.2%
+$0
12,451 sh
FGEN
Sell Eisner Mark · Chief Medical Officer · Open-market sale · filed Mar 6, 2023 ΔOwn −0.7%

Eisner Mark sold $26K of FGEN, trimming their stake 1%.

−$26K
1,187 sh @ $22
FGEN
Grant/award Eisner Mark · Chief Medical Officer · Grant/award · filed Feb 23, 2023 ΔOwn +23%
+$0
32,500 sh
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Dec 2, 2022 ΔOwn −0.8%
−$16.3K
1,084 sh @ $15
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Oct 4, 2022 ΔOwn −4.5%
−$88.2K
6,777 sh @ $13
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Sep 2, 2022 ΔOwn −0.5%
−$9.9K
756 sh @ $13
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Jun 3, 2022 ΔOwn −0.8%
−$11K
1,141 sh @ $10
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Apr 1, 2022 ΔOwn −4.1%
−$77.4K
6,442 sh @ $12
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Mar 3, 2022 ΔOwn −0.5%
−$10.3K
756 sh @ $14
FGEN
Grant/award Eisner Mark · Chief Medical Officer · Grant/award · filed Feb 16, 2022 ΔOwn +61%
+$0
60,000 sh
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Jan 5, 2022 ΔOwn −6.7%
−$104.4K
7,043 sh @ $15
FGEN
Tax withholding Eisner Mark · Chief Medical Officer · Tax withholding · filed Dec 3, 2021 ΔOwn −4.0%
−$54.9K
4,338 sh @ $13
FGEN
Grant/award Eisner Mark · Chief Medical Officer · Grant/award · filed Oct 6, 2021 ΔOwn +213%
+$0
74,520 sh
FGEN
Grant/award Eisner Mark · Incoming Chief Medical Officer · Grant/award · filed Dec 3, 2020 ΔOwn NEW
+$0
35,000 sh

Frequently asked questions

How is Eisner Mark's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Eisner Mark's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.